MD2035G2 - Metodă de micşorare a contracţiei vasculare induse de agenţii vasoconstrictori naturali - Google Patents

Metodă de micşorare a contracţiei vasculare induse de agenţii vasoconstrictori naturali

Info

Publication number
MD2035G2
MD2035G2 MDA20010172A MD20010172A MD2035G2 MD 2035 G2 MD2035 G2 MD 2035G2 MD A20010172 A MDA20010172 A MD A20010172A MD 20010172 A MD20010172 A MD 20010172A MD 2035 G2 MD2035 G2 MD 2035G2
Authority
MD
Moldova
Prior art keywords
decreasing
natural
contraction induced
vascular contraction
vasoconstrictor agents
Prior art date
Application number
MDA20010172A
Other languages
English (en)
Russian (ru)
Other versions
MD2035F1 (ro
Inventor
Михаил ПОПОВИЧ
Валериу КОБЕЦ
Виктория ИВАНОВ
Ион ПОПОВИЧ
Олег КАЛЕНИЧ
Михай ТОДИРАШ
Валентин ГУДУМАК
Валериу РУДИК
Original Assignee
Институтул Де Кардиолоджие Ал Министерулуй Сэнэтэций Дин Република Молдова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Институтул Де Кардиолоджие Ал Министерулуй Сэнэтэций Дин Република Молдова filed Critical Институтул Де Кардиолоджие Ал Министерулуй Сэнэтэций Дин Република Молдова
Priority to MDA20010172A priority Critical patent/MD2035G2/ro
Publication of MD2035F1 publication Critical patent/MD2035F1/ro
Publication of MD2035G2 publication Critical patent/MD2035G2/ro

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

Invenţia se referă la medicină, în special la cardiologie.Esenţa invenţiei constă în aceea că pentru micşorarea contracţiei vasculare induse de agenţii vasoconstrictori naturali, zilnic se administrează extract de spirulină în microdoze de 10…12 mg, per os, sau 41…49 µg/kilocorp intravenos, atingând astfel concentraţia serică eficientă de 55…65 µg%.
MDA20010172A 2001-05-28 2001-05-28 Metodă de micşorare a contracţiei vasculare induse de agenţii vasoconstrictori naturali MD2035G2 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20010172A MD2035G2 (ro) 2001-05-28 2001-05-28 Metodă de micşorare a contracţiei vasculare induse de agenţii vasoconstrictori naturali

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20010172A MD2035G2 (ro) 2001-05-28 2001-05-28 Metodă de micşorare a contracţiei vasculare induse de agenţii vasoconstrictori naturali

Publications (2)

Publication Number Publication Date
MD2035F1 MD2035F1 (ro) 2002-11-30
MD2035G2 true MD2035G2 (ro) 2003-05-31

Family

ID=19739861

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20010172A MD2035G2 (ro) 2001-05-28 2001-05-28 Metodă de micşorare a contracţiei vasculare induse de agenţii vasoconstrictori naturali

Country Status (1)

Country Link
MD (1) MD2035G2 (ro)

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Franz H. Meesseril, Current Cardiovascular Drug Therapy, New Orlean, 2000, p. 1400. *
Gavras H. Angiotensin-converting enzyme inhibition and the cardiovascular system, Hypertension. Nr. 23, 1994, p. 813…818. *
Thomas W. Smith,.Cardiovascular Therapeuticas, Brigham, 1996, p. 715. *
Чазов Е. И. Болезни органов кровообращения. Москва, 1997, с.831. *

Also Published As

Publication number Publication date
MD2035F1 (ro) 2002-11-30

Similar Documents

Publication Publication Date Title
GEP20063741B (en) Nonaryl-Heterocyclic NMDA/NR2B Antagonists
EA200501496A1 (ru) Высокоселективные ингибиторы обратного захвата норэпинефрина и способы их применения
WO1997049373A3 (en) Treatment and prevention of hiv infection by administration of derivatives of human chorionic gonadotropin
AU2002225772A1 (en) Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
BR0115109A (pt) Agentes terapêuticos e métodos de uso dos mesmos para a modulação da angiogênese
AR035927A1 (es) Compuesto de lactama (n)-((s)-2-hidroxi-3-metilbutiril)-1-(l-alaninil)-(s)-1-amino-3-metil-4,5,6,7-tetrahidro-2h-3-benzazepin-2-ona , composicion farmaceutica que lo comprende, procedimiento para la inhibicion de la liberacion de peptido b-amiloide y/o su sintesis que lo emplea y su uso para la fabr
BG101118A (en) Therapeutical compounds
TNSN07145A1 (fr) Derives de 2-amido-4-phenylthiazole, leur preparation et leur application en therapeutique
BR9912356A (pt) Regime de tratamento para a administração de fenilacetilglutamina, fenilacetilisoglutamina, e/ou fenilacetato
UA98462C2 (ru) Способы лечения аутоиммунных заболеваний с использованием слитой молекулы taci-ig
DE69928806D1 (de) (-)-pseudoephedrin als sympathomimetisches arzneimittel
CY1105545T1 (el) Θεραπεια στατινης για ενισχυση της διατηρησης νοητικης λειτουργιας
PL368686A1 (en) Novel aminobenzoephenones
WO2002005801A3 (en) Compositions containing diacyltartaric salts of (e)-metanicotine
MD2035G2 (ro) Metodă de micşorare a contracţiei vasculare induse de agenţii vasoconstrictori naturali
GEP20043377B (en) Pharmaceutical Complex
HUP9800623A2 (hu) (+)-O-demetil-tramadol felhasználása fájdalomcsillapító hatású orális gyógyszerkészítmények előállítására
MD1854F1 (ro) Metoda de tratament in insuficienta cardiaca congestiva
DE60305018D1 (de) Citalopram zur behandlung von bluthochdruck
WO2003066806A3 (en) Therapeutic use of aziridino compounds
HUP0300032A2 (en) Use of compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoreceptor for preparation of pharmaceutical composition
MXPA05003633A (es) 2"-oxo-voruscharina y derivados de la misma.
MD2164F1 (ro) Metoda de tratament al contuziilor oculare
BR0105968A (pt) Medicamento natural para tratamento alternativo anti-hiv

Legal Events

Date Code Title Description
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees